Butantan Institute's dengue vaccine protects
<p>Data from the Phase 3 clinical trial was published today (Thursday) in <em>The New England Journal of Medicine</em>. The vaccine is safe for both participants who have had dengue and those who have never been exposed to the virus before.</p>
Source: eurekalert.org